Inhibition of TLR4 protects rat islets against lipopolysaccharide-induced dysfunction

Xiao Wang1, Qin Min Ge1, Fan Bian2

  • 1Department of Emergency, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China.

Insights

Lipopolysaccharide (LPS) stress activates Toll-like receptor 4 (TLR4), causing pancreatic beta cell dysfunction and reduced insulin secretion. Inhibiting TLR4 may protect against LPS-induced oxidative stress and apoptosis in islets.

Area of Science:

  • Endocrinology
  • Immunology
  • Cell Biology

Background:

  • Oxidative stress impairs pancreatic beta cell function, reducing insulin secretion.
  • Toll-like receptor 4 (TLR4) activation by lipopolysaccharide (LPS) is implicated in inflammatory responses.
  • The role of LPS/TLR4 in oxidative stress-induced pancreatic beta cell apoptosis is unclear.

Purpose of the Study:

  • To investigate the role of TLR4 in LPS-induced oxidative stress, apoptosis, and insulin secretion dysfunction in rat islets.
  • To determine if inhibiting TLR4 can mitigate these LPS-induced effects.

Main Methods:

  • Isolated rat islets were exposed to LPS to stimulate TLR4.
  • Apoptosis markers (caspase-3, PARP, Bcl-2/Bax ratio) and reactive oxygen species (ROS) production were measured.
  • Insulin secretion was assessed.
  • TLR4 activity was inhibited using anti-TLR4 antibody and TLR4-short hairpin RNA (shRNA).

Main Results:

  • LPS stimulation of TLR4 increased ROS production and promoted apoptosis.
  • LPS exposure upregulated caspase-3 and PARP, and altered the Bcl-2/Bax ratio.
  • Insulin secretion from islets was significantly reduced following LPS exposure.
  • Inhibition of TLR4 reversed LPS-induced oxidative stress, apoptosis, and insulin secretion dysfunction.

Conclusions:

  • The LPS/TLR4 pathway partly mediates oxidative stress, apoptosis, and dysfunction in rat islets.
  • Inhibiting TLR4 may prevent LPS-induced islet dysfunction.
  • Targeting the LPS/TLR4 pathway combined with antioxidant therapy could be a novel treatment for hyperglycemia in septic patients.

Related Concept Videos